Compile Data Set for Download or QSAR
Report error Found 408 Enz. Inhib. hit(s) with all data for entry = 12867
TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735202BDBM735202(US20250129078, Compound 220)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735199BDBM735199(US20250129078, Compound 217)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735198BDBM735198(US20250129078, Compound 216)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735181BDBM735181(US20250129078, Compound 199)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735180BDBM735180(US20250129078, Compound 198)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735176BDBM735176(US20250129078, Compound 194)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735182BDBM735182(US20250129078, Compound 200)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735226BDBM735226(US20250129078, Compound 244)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735237BDBM735237(US20250129078, Compound 255)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735236BDBM735236(US20250129078, Compound 254)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735234BDBM735234(US20250129078, Compound 252)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735231BDBM735231(US20250129078, Compound 249)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735219BDBM735219(US20250129078, Compound 237)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735218BDBM735218(US20250129078, Compound 236)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735217BDBM735217(US20250129078, Compound 235)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735216BDBM735216(1-(4-(8-((4-(imidazo[1,2-b]pyridazin-7-yloxy)-3-me...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735003BDBM735003(US20250129078, Compound 21)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735258BDBM735258(US20250129078, Compound 276)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735012BDBM735012(US20250129078, Compound 30)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735007BDBM735007(US20250129078, Compound 25)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735263BDBM735263(US20250129078, Compound 281)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735006BDBM735006(US20250129078, Compound 24)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 734989BDBM734989(US20250129078, Compound 7)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735245BDBM735245(US20250129078, Compound 263)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735244BDBM735244(US20250129078, Compound 262)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 734986BDBM734986(US20250129078, Compound 5)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 734983BDBM734983(US20250129078, Compound 4)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735239BDBM735239(US20250129078, Compound 257)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 734993BDBM734993(US20250129078, Compound 11)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 734990BDBM734990(US20250129078, Compound 8)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735292BDBM735292(US20250129078, Compound 310)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735287BDBM735287(US20250129078, Compound 305)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735030BDBM735030(US20250129078, Compound 48)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735301BDBM735301(US20250129078, Compound 319)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735044BDBM735044(US20250129078, Compound 62)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735300BDBM735300(US20250129078, Compound 318)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735295BDBM735295(US20250129078, Compound 313)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735020BDBM735020(US20250129078, Compound 38)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735018BDBM735018(US20250129078, Compound 36)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735270BDBM735270(US20250129078, Compound 288)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735029BDBM735029(US20250129078, Compound 47)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735285BDBM735285(US20250129078, Compound 303)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735028BDBM735028(US20250129078, Compound 46)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735284BDBM735284(US20250129078, Compound 302)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735026BDBM735026(US20250129078, Compound 44)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735024BDBM735024(US20250129078, Compound 42)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735023BDBM735023(US20250129078, Compound 41)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735066BDBM735066((R)-2-(1-acryloyl-4-(4-((3-methyl-4-((1-methyl-H-b...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735065BDBM735065((S)-2-(1-acryloyl-4-(4-((3-methyl-4-((1-methyl-1H-...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 735064BDBM735064(US20250129078, Compound 82)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 408 total ) | Next | Last >>
Jump to: